Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence
Conclusions
Cannabis, cannabis-derived products and synthetic cannabinoids may slightly reduce disease activity in patients with RA. Its use may result in little to no difference in pain reduction and may slightly increase nervous system adverse events. The evidence is very uncertain about the effect of cannabis, cannabis-derived products, and synthetic cannabinoids on serious adverse events risk.
Source: JCR: Journal of Clinical Rheumatology - Category: Rheumatology Tags: Reviews Source Type: research
More News: Arthritis | Databases & Libraries | Pain | Pain Management | Rheumatoid Arthritis | Rheumatology | Study